ASCO GU 2023 Conference Coverage
Playback speed
10 seconds
FDA Announcement Based on the MAGNITUDE Trial: Niraparib With Abiraterone Acetate and Prednisone in Patients With mCRPC and Homologous Recombination Repair Gene Alterations
By
ASCO GU 2023 Conference Coverage
FEATURING
Eleni Efstathiou
By
ASCO GU 2023 Conference Coverage
FEATURING
Eleni Efstathiou
188 views
February 28, 2023
Login to view comments.
Click here to Login
Videos